(lp0
S"Imprimis Pharmaceuticals Strengthens Senior Leadership Team with Key Hires in ... PR Newswire  - Aug 15, 2016 SAN DIEGO, Aug. 15, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding business model, today reported the expansion of its&nbsp;...Imprimis Pharmaceuticals'  CEO Mark Baum on Q2 2016 Results - Earnings ... - Seeking Alpha"
p1
aS'Imprimis Pharmaceuticals Registers its New Jersey Facility with the FDA as an ... PR Newswire  - Oct 28, 2016 SAN DIEGO, Oct. 28, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today announced that it has filed for&nbsp;...'
p2
aS'Imprimis Pharmaceuticals Announces Third Quarter 2016 Financial Results PR Newswire  - Nov 14, 2016 14, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today reported financial results for the third quarter 2016.'
p3
aS'Imprimis Pharmaceuticals Announces Availability of Lower-Cost Option for the ... PR Newswire  - Oct 17, 2016 SAN DIEGO, Oct. 17, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the production and dispensing of high quality innovative compounded medications, today announced the availability of a&nbsp;...'
p4
aS'Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 ... Yahoo Finance - Mar 7, 2017 SAN DIEGO, March 7, 2017 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , an ophthalmology-focused pharmaceutical company, today reported it will release fourth quarter and fiscal year 2016 financial results after the close of trading on Tuesday,&nbsp;...'
p5
aS"Imprimis Pharmaceuticals Announces $9.8 Million Private Placement of Units PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc.  today announced that it has entered into a definitive securities purchase agreement with various accredited investors and certain members of Imprimis' Board of&nbsp;...Imprimis Pharmaceuticals Inc  CEO Mark L Baum Bought $279240 of Shares - GuruFocus.com"
p6
aS'Stock Focus: Checking Levels on Imprimis Pharmaceuticals Inc  Rives Journal - 15 hours ago Investors may be looking at some different technical levels in order to get a better grasp on the markets. Presently, the 14-day ADX for Imprimis Pharmaceuticals Inc  is 12.6. In general, an ADX value from 0-25 would signal an absent or weak trend.'
p7
aS'Imprimis Pharmaceuticals Announces Plans to Register its Texas Pharmacy with ... PR Newswire  - Oct 29, 2015 SAN DIEGO, Oct. 29, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary compounded drug therapies, announced that it has&nbsp;...'
p8
aS'Imprimis Pharmaceuticals Announces Preliminary Revenue for Third Quarter 2015 PR Newswire  - Oct 20, 2015 SAN DIEGO, Oct. 20, 2015 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. , a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that estimated&nbsp;...'
p9
aS'Imprimis Pharmaceuticals Inc. IMMY  Wall Street Journal - Feb 8, 2013 News Imprimis Pharmaceuticals Inc.IMMY. Significant News Only. 03/07/17; Press Release. Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2016 Financial Report Conference Call and Webcast on March 21, 2017 at 4:30 p.m.'
p10
a.